Opportunities in traditional pharma companies with a focus on domestic formulations and US generic drugs are drying up ...

Opportunities in traditional pharma companies with a focus on domestic formulations and US generics are drying up because of a slowdown in new approvals and regulatory issues.

Wang Jian, the founder of Alibaba's powerful cloud computing unit, gave an extended interview to Bloomberg that was posted on ...

Even as artificial intelligence (AI) spurs demand for tech companies, boosting their top and bottom lines, an industry ...